000075773 001__ 75773 000075773 005__ 20200117221649.0 000075773 0247_ $$2doi$$a10.1016/j.jvir.2017.09.011 000075773 0248_ $$2sideral$$a102151 000075773 037__ $$aART-2018-102151 000075773 041__ $$aeng 000075773 100__ $$0(orcid)0000-0002-0113-5121$$aGuirola, Jose A. 000075773 245__ $$aA Randomized Trial of Endovascular Embolization Treatment in Pelvic Congestion Syndrome: Fibered Platinum Coils versus Vascular Plugs with 1-Year Clinical Outcomes 000075773 260__ $$c2018 000075773 5060_ $$aAccess copy available to the general public$$fUnrestricted 000075773 5203_ $$aPurpose: To compare safety and efficacy of vascular plugs (VPs) and fibered platinum coils (FPCs) for embolization in pelvic congestion syndrome (PCS). Materials and Methods A randomized, prospective, single-center study enrolled 100 women with PCS from January 2014 to January 2015. Patients were randomly assigned to 2 groups, and embolization was performed with FPCs (n = 50) or VPs (n = 50). Mean age of patients was 42.7 years ± 7.60, and mean visual analog scale (VAS) score for pelvic pain before treatment was 7.4 ± 7.60. Primary outcome (clinical success at 1 y using a VAS), number of devices, procedure and fluoroscopy times, radiation doses, costs, and complications were compared, and participants were followed at 1, 3, 6, and 12 months. Results: Clinical success and subjective improvement were not significantly different at 1-year follow-up (89.7% for FPCs vs 90.6% for VPs; P = .760). Mean number of devices per case was 18.2 ± 1.33 for FPCs and 4.1 ± 0.31 for VPs (P < .001). Three FPCs and 1 VP migrated to pulmonary vasculature approximately 3–6 months after the embolization procedure; all were retrieved without complications. The FPC group had a significantly longer fluoroscopy time (33.4 min ± 4.68 vs 19.5 min ± 6.14) and larger radiation dose (air kerma 948.0 mGy ± 248.45 vs 320.7 mGy ± 134.33) (all P < .001). Conclusions: Embolization for PCS resulted in pain relief in 90% of patients; clinical success was not affected by embolic device. VPs were associated with decreased fluoroscopy time and radiation dose. 000075773 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-nd$$uhttp://creativecommons.org/licenses/by-nc-nd/3.0/es/ 000075773 590__ $$a2.828$$b2018 000075773 591__ $$aRADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING$$b44 / 129 = 0.341$$c2018$$dQ2$$eT2 000075773 591__ $$aPERIPHERAL VASCULAR DISEASE$$b27 / 65 = 0.415$$c2018$$dQ2$$eT2 000075773 592__ $$a0.912$$b2018 000075773 593__ $$aCardiology and Cardiovascular Medicine$$c2018$$dQ1 000075773 593__ $$aRadiology, Nuclear Medicine and Imaging$$c2018$$dQ1 000075773 593__ $$aMedicine (miscellaneous)$$c2018$$dQ1 000075773 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/acceptedVersion 000075773 700__ $$aSanchez-Ballestin, Maria 000075773 700__ $$aSierre, Sergio 000075773 700__ $$0(orcid)0000-0003-3865-0925$$aLahuerta, Celia 000075773 700__ $$aMayoral, Victoria 000075773 700__ $$0(orcid)0000-0002-5618-7519$$aDe Gregorio, Miguel A.$$uUniversidad de Zaragoza 000075773 7102_ $$11010$$2770$$aUniversidad de Zaragoza$$bDpto. Pediatría Radiol.Med.Fís$$cÁrea Radiol. y Medicina Física 000075773 773__ $$g29, 1 (2018), 45-53$$pJ. vasc. interv. radiol.$$tJournal of vascular and interventional radiology$$x1051-0443 000075773 8564_ $$s2671144$$uhttps://zaguan.unizar.es/record/75773/files/texto_completo.pdf$$yPostprint 000075773 8564_ $$s94894$$uhttps://zaguan.unizar.es/record/75773/files/texto_completo.jpg?subformat=icon$$xicon$$yPostprint 000075773 909CO $$ooai:zaguan.unizar.es:75773$$particulos$$pdriver 000075773 951__ $$a2020-01-17-22:07:53 000075773 980__ $$aARTICLE